Semaglutide/Cyanocobalamin Injectable — Class II drug recall D-0481-2025
Ongoing recall by Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado), reported 2025-07-02, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0481-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Thrive Health and Wellness, LLC, dba Thrive Health Solutions (Colorado), Englewood, CO, United States |
| Recall initiated | 2025-05-21 |
| Classified | 2025-06-20 |
| Reported by FDA | 2025-07-02 |
| Distributed | Nationwide (US) |
| Quantity | 28 syringes |
| Reason classes | sterility |
| Lot numbers | C03075J |
Product
Semaglutide/Cyanocobalamin Injectable, 5mg/1mg/mL, pre-filled syringe, Thrive Health Solutions, 88 Inverness, Cir E, Suite A-204, Englewood, CO 80112
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0481-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.